Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Therapeutic Targeting of CCR1 to Prevent Dissemination of Multiple Myeloma Plasma Cells

Mara N Zeissig, BS, Duncan R Hewett, PhD, Krzysztof M Mrozik, PhD, Vasilios Panagopoulos, PhD, Monika Engelhardt, MD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Peter J Croucher, PhD, Andrew CW Zannettino, PhD, Kate Vandyke, PhD

Blood (2019) 134 (Supplement_1): 3099.

https://doi.org/10.1182/blood-2019-121974

Published: 2019

Journal Articles

Red Cell Alloimmunisation Is Associated with Increased Red Cell Transfusion Requirements in Myelodysplastic Syndrome

Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Romi Sinha, MBBS, Monika M Kutyna, MSc, Soumya Gupta, Lakshmi Nath, MDDM,FRCPA, Shriram V. Nath, MDDM, FRCPA, FRACP, Nicholas Wickham, FRCPA, FRACP, FRCPath, Ian D Lewis, MBBS,PhD, David M Ross, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Deepak Singhal, MBBS, MDFRACP, FRCPA, David John Roxby, B App Sc, M App Sc, ARCPA, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2018) 132 (Supplement 1): 1826.

https://doi.org/10.1182/blood-2018-99-115848

Published: 2018

Journal Articles

Geriatric Assessment in Older People with Myelodysplasia Is Predictive of Azacitidine Therapy Completion and Survival: A Prospective Interventional Study at the Royal Adelaide Hospital

Angela Molga, MBBS, FRACP, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Deepak Singhal, MBBS, MD FRACP, FRCPA, Nimit Singhal, MBBS MDDM FRACP, David M Ross, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Peter G Bardy, MBBS, FRACP, FRCPA, FRCPath, Pratyush Giri, MBBS, FRACP, FRCPA, Gillian Caughey, PhD, Sepehr Shakib, MBBS, FRACP, PhD, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2018) 132 (Supplement 1): 3101.

https://doi.org/10.1182/blood-2018-99-117853

Published: 2018

Journal Articles

Whole Exome Sequencing of Paired MGUS/SMM to MM Patients Reveals Novel Subclonal Tumour Evolution Models in Disease Progression of Multiple Myeloma

Ankit K. Dutta, John P. Grady, BSc, MSc, PhD, Duncan R. Hewett, BA (Hons), PhD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Lynn Fink, PhD, Andrew C. W. Zannettino, BSc (Hons), PhD

Blood (2017) 130 (Supplement 1): 391.

https://doi.org/10.1182/blood.V130.Suppl_1.391.391

Published: 2017

Journal Articles

Presence of Rare Germline Variants in Fanconi Anaemia Pathway Genes Confers a Poor Prognosis Comparable to TP53 Mutations in Therapy-Related Myeloid Neoplasms

Blood (2017) 130 (Supplement 1): 4231.

https://doi.org/10.1182/blood.V130.Suppl_1.4231.4231

Published: 2017

Journal Articles

Red Cell Alloimmunisation Is Associated with Development of Autoantibodies and Increased Red Cell Transfusion Requirements in Myelodysplastic Syndromes (MDS)

Deepak Singhal, MBBS, MD FRCPA, FRACP, Monika M Kutyna, MSc, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Sophia Hague, Lakshmi Nath, MDDM,FRCPA, Shriram V Nath, MBBS, DM, FRCPA, Romi Sinha, MBBS, Nicholas Wickham, FRCPA,FRACP,FRCPath, Ian D Lewis, MBBS, PhD FRACP, FRCPA, David M Ross, MBBS, PhD FRACP, FRCPA, Peter G Bardy, MBBS, FRACP, FRCPA, FRCPath, Luen Bik To, MBBS, FRACP, FRCPA, PhD, John Reynolds, PhD, Erica Wood, David John Roxby, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2017) 130 (Supplement 1): 2411.

https://doi.org/10.1182/blood.V130.Suppl_1.2411.2411

Published: 2017

Journal Articles

A Geriatric Screening Tool (G8) Provides an Independent Prognostic Index for Azacitidine Treated Elderly MDS Patients

Angela Molga, MBBS, FRACP, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Deepak Singhal, MBBS, MD FRCPA, FRACP, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Lucy Cussans, Nimit Singhal, MBBS MDDM FRACP, Gillian Caughey, PhD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Peter Bardy, MBBS, FRACP, FRCPA, FRCPath, Sepehr Shakib, MBBS, FRACP, PhD, Ian D Lewis, MBBS, PhD FRACP, FRCPA, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2017) 130 (Supplement 1): 1692.

https://doi.org/10.1182/blood.V130.Suppl_1.1692.1692

Published: 2017

Journal Articles

HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma

Mara N Zeissig, BSc, Duncan R. Hewett, BA (Hons), PhD, Sally Martin, PhD, Krzysztof M Mrozik, BSc, Chee Man Cheong, PhD, Peter Diamond, PhD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Stan Gronthos, PhD, Daniel J Peet, PhD, Peter I Croucher, BSc, PhD, Kate Vandyke, PhD, Andrew C. W. Zannettino, BSc (Hons), PhD

Blood (2017) 130 (Supplement 1): 4425.

https://doi.org/10.1182/blood.V130.Suppl_1.4425.4425

Published: 2017

Journal Articles

Hypermethylation of GADD45A Defines a Methylation Profile Distinct to Mutant IDH1/2 , and Correlates with More Aggressive AML

Blood (2016) 128 (22): 2877.

https://doi.org/10.1182/blood.V128.22.2877.2877

Published: 2016

Journal Articles

The Frequency of Genetic Mutations in T-MN Is High and Comparable to Primary MDS but the Spectrum Is Different

Blood (2016) 128 (22): 3157.

https://doi.org/10.1182/blood.V128.22.3157.3157

Published: 2016

Journal Articles

Rare Variants Affecting the Fanconi Anaemia DNA Repair Genes Associate with Increased Risk for AML

Kyaw Ze Ya Maung, BSc, Paul Leo, PhD, Anna L Brown, PhD, Mahmoud A Bassal, Bsc, BCompSc, Debora A. Casolari, PhD, Adam Ewing, B.A & PhD, Emma Duncan, PhD, Sarah C Bray, PhD, Evgeny Glazov, PhD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Russell Saal, MMSc, BSMedTech, Ian D Lewis, MBBS, PhD FRACP, FRCPA, Devinder S Gill, MBChB FRCPath MRCP, Paula Marlton, MBBS, FRACP, FRCPA, James X Gray, MD PhD, Thomas J Gonda, PhD, Richard D'Andrea, PhD

Blood (2016) 128 (22): 41.

https://doi.org/10.1182/blood.V128.22.41.41

Published: 2016

NARROW

Therapeutic Targeting of CCR1 to Prevent Dissemination of Multiple Myeloma Plasma Cells

Red Cell Alloimmunisation Is Associated with Increased Red Cell Transfusion Requirements in Myelodysplastic Syndrome

Geriatric Assessment in Older People with Myelodysplasia Is Predictive of Azacitidine Therapy Completion and Survival: A Prospective Interventional Study at the Royal Adelaide Hospital

Whole Exome Sequencing of Paired MGUS/SMM to MM Patients Reveals Novel Subclonal Tumour Evolution Models in Disease Progression of Multiple Myeloma

Presence of Rare Germline Variants in Fanconi Anaemia Pathway Genes Confers a Poor Prognosis Comparable to TP53 Mutations in Therapy-Related Myeloid Neoplasms

Red Cell Alloimmunisation Is Associated with Development of Autoantibodies and Increased Red Cell Transfusion Requirements in Myelodysplastic Syndromes (MDS)

A Geriatric Screening Tool (G8) Provides an Independent Prognostic Index for Azacitidine Treated Elderly MDS Patients

HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma

Hypermethylation of GADD45A Defines a Methylation Profile Distinct to Mutant IDH1/2 , and Correlates with More Aggressive AML

The Frequency of Genetic Mutations in T-MN Is High and Comparable to Primary MDS but the Spectrum Is Different

Rare Variants Affecting the Fanconi Anaemia DNA Repair Genes Associate with Increased Risk for AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only